Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology

References

• Ahuja N, Schwer B, Carobbio S, Waltregny D, North BJ, Castronovo V, Maechler P, Verdin E. 2007. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem. 282:33583–33592.
   PubMed Web of Science ®Google Scholar
• Alvarez-Lario B, Macarron-Vicente J. 2010. Uric acid and evolution. Rheumatology (Oxford). 49:2010–2015.
   PubMed Web of Science ®Google Scholar
• Anderson KA, Huynh FK, Fisher-Wellman K, Stuart JD, Peterson BS, Douros JD, Wagner GR, Thompson JW, Madsen AS, Green MF, et al. 2017. SIRT4 Is a lysine deacylase that controls leucine metabolism and insulin secretion. Cell Metab. 25:838–855 e815.
   PubMed Web of Science ®Google Scholar
• Audagnotto M, Dal Peraro M. 2017. Protein post-translational modifications: in silicoprediction tools and molecular modeling. Comput Struct Biotechnol J. 15:307–319.
   PubMed Web of Science ®Google Scholar
• Balendiran GK, Dabur R, Fraser D. 2004. The role of glutathione in cancer. Cell Biochem Funct. 22:343–352.
   PubMed Web of Science ®Google Scholar
• Bao X, Wang Y, Li X, Li XM, Liu Z, Yang T, Wong CF, Zhang J, Hao Q, Li XD. 2014. Identification of ‘erasers’ for lysine crotonylated histone marks using a chemical proteomics approach. Elife. 3:e02999.
   PubMed Web of Science ®Google Scholar
• Barber MF, Michishita-Kioi E, Xi Y, Tasselli L, Kioi M, Moqtaderi Z, Tennen RI, Paredes S, Young NL, Chen K, et al. 2012. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature. 487:114–118.
   PubMed Web of Science ®Google Scholar
• Bartosch C, Monteiro-Reis S, Almeida-Rios D, Vieira R, Castro A, Moutinho M, Rodrigues M, Graca I, Lopes JM, Jeronimo C. 2016. Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium. Oncotarget. 7:1144–1154.
   PubMedGoogle Scholar
• Beitz JM. 2014. Parkinson’s disease: a review. Front Biosci (Schol Ed). 6:65–74.
   PubMedGoogle Scholar
• Ben-Ari Y, Cossart R. 2000. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 23:580–587.
   PubMed Web of Science ®Google Scholar
• Boylston JA, Sun J, Chen Y, Gucek M, Sack MN, Murphy E. 2015. Characterization of the cardiac succinylome and its role in ischemia-reperfusion injury. J Mol Cell Cardiol. 88:73–81.
   PubMed Web of Science ®Google Scholar
• Bringman-Rodenbarger LR, Guo AH, Lyssiotis CA, Lombard DB. 2017. Emerging roles for SIRT5 in metabolism and cancer. Antioxid Redox Signal. 28:677–690.
   PubMed Web of Science ®Google Scholar
• Buler M, Aatsinki SM, Izzi V, Uusimaa J, Hakkola J. 2014. SIRT5 is under the control of PGC-1α and AMPK and is involved in regulation of mitochondrial energy metabolism. FASEB J. 28:3225–3237.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N. 2011. Integrated genomic analyses of ovarian carcinoma. Nature. 474:609–615.
   PubMed Web of Science ®Google Scholar
• Chalkiadaki A, Guarente L. 2015. The multifaceted functions of sirtuins in cancer. Nat Rev Cancer. 15:608–624.
   PubMed Web of Science ®Google Scholar
• Chang L, Xi L, Liu Y, Liu R, Wu Z, Jian Z. 2018. SIRT5 promotes cell proliferation and invasion in hepatocellular carcinoma by targeting E2F1. Mol Med Rep. 17:342–349.
   PubMed Web of Science ®Google Scholar
• Chen S, Blank MF, Iyer A, Huang B, Wang L, Grummt I, Voit R. 2016. SIRT7-dependent deacetylation of the U3-55k protein controls pre-rRNA processing. Nat Commun. 7:10734.
   PubMed Web of Science ®Google Scholar
• Chen S, Seiler J, Santiago-Reichelt M, Felbel K, Grummt I, Voit R. 2013. Repression of RNA polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of PAF53 by SIRT7. Mol Cell. 52:303–313.
   PubMed Web of Science ®Google Scholar
• Chen XF, Tian MX, Sun RQ, Zhang ML, Zhou LS, Jin L, Chen LL, Zhou WJ, Duan KL, Chen YJ, et al. 2018. SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer. EMBO Rep. https://doi.org/10.15252/embr.201745124.
   Google Scholar
• Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier SY, Robb EL, Logan A, Nadtochiy SM, Ord ENJ, Smith AC, et al. 2014. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 515:431–435.
   PubMed Web of Science ®Google Scholar
• Chypre M, Zaidi N, Smans K. 2012. ATP-citrate lyase: a mini-review. Biochem Biophys Res Commun. 422:1–4.
   PubMed Web of Science ®Google Scholar
• Circu ML, Aw TY. 2010. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 48:749–762.
   PubMed Web of Science ®Google Scholar
• Clark O, Yen K, Mellinghoff IK. 2016. Molecular pathways: isocitrate dehydrogenase mutations in cancer. Clin Cancer Res. 22:1837–1842.
   PubMed Web of Science ®Google Scholar
• Cluntun AA, Lukey MJ, Cerione RA, Locasale JW. 2017. Glutamine metabolism in cancer: understanding the heterogeneity. Trends Cancer. 3:169–180.
   PubMed Web of Science ®Google Scholar
• Colak G, Pougovkina O, Dai L, Tan M, Te Brinke H, Huang H, Cheng Z, Park J, Wan X, Liu X, et al. 2015. Proteomic and biochemical studies of lysine malonylation suggest its malonic aciduria-associated regulatory role in mitochondrial function and fatty acid oxidation. Mol Cell Proteomics. 14:3056–3071.
   PubMed Web of Science ®Google Scholar
• Cooper HM, Spelbrink JN. 2008. The human SIRT3 protein deacetylase is exclusively mitochondrial. Biochem J. 411:279–285.
   PubMed Web of Science ®Google Scholar
• Coordinators NR. 2018. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 46(D1):D8–D13.
   Web of Science ®Google Scholar
• Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, et al. 2009. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 462:739–744.
   PubMed Web of Science ®Google Scholar
• Dave KR, Anthony Defazio R, Raval AP, Dashkin O, Saul I, Iceman KE, Perez-Pinzon MA, Drew KL. 2009. Protein kinase C epsilon activation delays neuronal depolarization during cardiac arrest in the euthermic arctic ground squirrel. J Neurochem. 110:1170–1179.
   PubMed Web of Science ®Google Scholar
• Dave KR, DeFazio RA, Raval AP, Torraco A, Saul I, Barrientos A, Perez-Pinzon MA. 2008. Ischemic preconditioning targets the respiration of synaptic mitochondria via protein kinase C epsilon. J Neurosci. 28:4172–4182.
   PubMed Web of Science ®Google Scholar
• Della-Morte D, Raval AP, Dave KR, Lin HW, Perez-Pinzon MA. 2011. Post-ischemic activation of protein kinase C ε protects the hippocampus from cerebral ischemic injury via alterations in cerebral blood flow. Neurosci Lett. 487:158–162.
   PubMed Web of Science ®Google Scholar
• Donlon TA, Morris BJ, Chen R, Masaki KH, Allsopp RC, Willcox DC, Tiirikainen M, Willcox BJ. 2017. Analysis of polymorphisms in 58 potential candidate genes for association with human longevity. J Gerontol A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glx247.
   Web of Science ®Google Scholar
• Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA. 2003. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol. 23:3173–3185.
   PubMed Web of Science ®Google Scholar
• Du J, Zhou Y, Su X, Yu JJ, Khan S, Jiang H, Kim J, Woo J, Kim JH, Choi BH, et al. 2011. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science. 334:806–809.
   PubMed Web of Science ®Google Scholar
• Du Z, Liu X, Chen T, Gao W, Wu Z, Hu Z, Wei D, Gao C, Li Q. 2018. Targeting a Sirt5-positive subpopulation overcomes multidrug resistance in wild-type kras colorectal carcinomas. Cell Rep. 22:2677–2689.
   PubMed Web of Science ®Google Scholar
• Ducker GS, Rabinowitz JD. 2017. One-carbon metabolism in health and disease. Cell Metab. 25:27–42.
   PubMed Web of Science ®Google Scholar
• Fatkins DG, Monnot AD, Zheng W. 2006. Nepsilon-thioacetyl-lysine: a multi-facet functional probe for enzymatic protein lysine Nepsilon-deacetylation. Bioorg Med Chem Lett. 16:3651–3656.
   PubMed Web of Science ®Google Scholar
• Feldman JL, Baeza J, Denu JM. 2013. Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins. J Biol Chem. 288:31350–31356.
   PubMed Web of Science ®Google Scholar
• Fischer F, Gertz M, Suenkel B, Lakshminarasimhan M, Schutkowski M, Steegborn C. 2012. Sirt5 deacylation activities show differential sensitivities to nicotinamide inhibition. PLoS One. 7:e45098.
   PubMed Web of Science ®Google Scholar
• Ford E, Voit R, Liszt G, Magin C, Grummt I, Guarente L. 2006. Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20:1075–1080.
   PubMed Web of Science ®Google Scholar
• Fould B, Garlatti V, Neumann E, Fenel D, Gaboriaud C, Arlaud GJ. 2010. Structural and functional characterization of the recombinant human mitochondrial trifunctional protein. Biochemistry. 49:8608–8617.
   PubMed Web of Science ®Google Scholar
• Frye RA. 2000. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun. 273:793–798.
   PubMed Web of Science ®Google Scholar
• Fujii T, Khawaja MR, DiNardo CD, Atkins JT, Janku F. 2016. Targeting isocitrate dehydrogenase (IDH) in cancer. Discov Med. 21:373–380.
   PubMed Web of Science ®Google Scholar
• Gao J, Wang L, Liu J, Xie F, Su B, Wang X. 2017. Abnormalities of mitochondrial dynamics in neurodegenerative diseases. Antioxidants (Basel). 6:E25.
   PubMedGoogle Scholar
• Gao X, Wang H, Yang JJ, Liu X, Liu ZR. 2012. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell. 45:598–609.
   PubMed Web of Science ®Google Scholar
• Geng YQ, Li TT, Liu XY, Li ZH, Fu YC. 2011. SIRT1 and SIRT5 activity expression and behavioral responses to calorie restriction. J Cell Biochem. 112:3755–3761.
   PubMed Web of Science ®Google Scholar
• Gertz M, Nguyen GT, Fischer F, Suenkel B, Schlicker C, Franzel B, Tomaschewski J, Aladini F, Becker C, Wolters D, et al. 2012. A molecular mechanism for direct sirtuin activation by resveratrol. PLoS One. 7:e49761.
   PubMed Web of Science ®Google Scholar
• Gertz M, Steegborn C. 2016. Using mitochondrial sirtuins as drug targets: disease implications and available compounds. Cell Mol Life Sci. 73:2871–2896.
   PubMed Web of Science ®Google Scholar
• Glorioso C, Oh S, Douillard GG, Sibille E. 2011. Brain molecular aging, promotion of neurological disease and modulation by sirtuin 5 longevity gene polymorphism. Neurobiol Dis. 41:279–290.
   PubMed Web of Science ®Google Scholar
• Grozinger CM, Chao ED, Blackwell HE, Moazed D, Schreiber SL. 2001. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J Biol Chem. 276:38837–38843.
   PubMed Web of Science ®Google Scholar
• Guan D, Lim JH, Peng L, Liu Y, Lam M, Seto E, Kao HY. 2014. Deacetylation of the tumor suppressor protein PML regulates hydrogen peroxide-induced cell death. Cell Death Dis. 5:e1340.
   PubMed Web of Science ®Google Scholar
• Guedouari H, Daigle T, Scorrano L, Hebert-Chatelain E. 2017. Sirtuin 5 protects mitochondria from fragmentation and degradation during starvation. Biochim Biophys Acta. 1864:169–176.
   PubMed Web of Science ®Google Scholar
• Guetschow ED, Kumar S, Lombard DB, Kennedy RT. 2016. Identification of sirtuin 5 inhibitors by ultrafast microchip electrophoresis using nanoliter volume samples. Anal Bioanal Chem. 408:721–731.
   PubMed Web of Science ®Google Scholar
• Hagner N, Joerger M. 2010. Cancer chemotherapy: targeting folic acid synthesis. Cancer Manag Res. 2:293–301.
   PubMedGoogle Scholar
• Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, Murphy AJ, Valenzuela DM, Yancopoulos GD, Karow M, Blander G, et al. 2006. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell. 126:941–954.
   PubMed Web of Science ®Google Scholar
• Haussinger D. 1990. Nitrogen metabolism in liver: structural and functional organization and physiological relevance. Biochem J. 267:281–290.
   PubMed Web of Science ®Google Scholar
• Hawse WF, Hoff KG, Fatkins DG, Daines A, Zubkova OV, Schramm VL, Zheng W, Wolberger C. 2008. Structural insights into intermediate steps in the Sir2 deacetylation reaction. Structure. 16:1368–1377.
   PubMed Web of Science ®Google Scholar
• He B, Du J, Lin H. 2012. Thiosuccinyl peptides as Sirt5-specific inhibitors. J Am Chem Soc. 134:1922–1925.
   PubMed Web of Science ®Google Scholar
• Heltweg B, Gatbonton T, Schuler AD, Posakony J, Li H, Goehle S, Kollipara R, Depinho RA, Gu Y, Simon JA, et al. 2006. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res. 66:4368–4377.
   PubMed Web of Science ®Google Scholar
• Hershberger KA, Abraham DM, Martin AS, Mao L, Liu J, Gu H, Locasale JW, Hirschey MD. 2017. Sirtuin 5 is required for mouse survival in response to cardiac pressure overload. J Biol Chem. 292:19767–19781.
   PubMed Web of Science ®Google Scholar
• Hershberger KA, Martin AS, Hirschey MD. 2017. Role of NAD + and mitochondrial sirtuins in cardiac and renal diseases. Nat Rev Nephrol. 13:213–225.
   PubMed Web of Science ®Google Scholar
• Hirschey MD, Zhao Y. 2015. Metabolic regulation by lysine malonylation, succinylation, and glutarylation. Mol Cell Proteomics. 14:2308–2315.
   PubMed Web of Science ®Google Scholar
• Holmstrom KM, Finkel T. 2014. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 15:411–421.
   PubMed Web of Science ®Google Scholar
• Houten SM, Wanders RJ. 2010. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation. J Inherit Metab Dis. 33:469–477.
   PubMed Web of Science ®Google Scholar
• Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, et al. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 425:191–196.
   PubMed Web of Science ®Google Scholar
• Igci M, Kalender ME, Borazan E, Bozgeyik I, Bayraktar R, Bozgeyik E, Camci C, Arslan A. 2016. High-throughput screening of Sirtuin family of genes in breast cancer. Gene. 586:123–128.
   PubMed Web of Science ®Google Scholar
• Imai S, Guarente L. 2010. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci. 31:212–220.
   PubMed Web of Science ®Google Scholar
• Imai SI, Guarente L. 2016. It takes two to tango: NAD +  and sirtuins in aging/longevity control. NPJ Aging Mech Dis. 2:16017.
   PubMed Web of Science ®Google Scholar
• Jaiswal AK. 2004. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med. 36:1199–1207.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Li X, Yang W, Hawke DH, Zheng Y, Xia Y, Aldape K, Wei C, Guo F, Chen Y, et al. 2014. PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Mol Cell. 53:75–87.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Liu J, Chen D, Yan L, Zheng W. 2017. Sirtuin inhibition: strategies, inhibitors, and therapeutic potential. Trends Pharmacol Sci. 38:459–472.
   PubMed Web of Science ®Google Scholar
• Kaidi A, Weinert BT, Choudhary C, Jackson SP. 2010. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science. 329:1348–1353.
   PubMed Web of Science ®Google Scholar
• Kalbas D, Liebscher S, Nowak T, Meleshin M, Pannek M, Popp C, Alhalabi Z, Bordusa F, Sippl W, Steegborn C, et al. 2018. Potent and selective inhibitors of human Sirtuin 5. J Med Chem. 61:2460–2471.
   PubMed Web of Science ®Google Scholar
• Kashfi K, Mynatt RL, Park EA, Cook GA. 2011. Membrane microenvironment regulation of carnitine palmitoyltranferases I and II. Biochem Soc Trans. 39:833–837.
   PubMed Web of Science ®Google Scholar
• Koronowski KB, Khoury N, Morris-Blanco KC, Stradecki-Cohan HM, Garrett TJ, Perez-Pinzon MA. 2018. Metabolomics based identification of SIRT5 and protein kinase C epsilon regulated pathways in brain. Front Neurosci. 12:32.
   PubMed Web of Science ®Google Scholar
• Kuciel R, Mazurkiewicz A. 2004. Formation and detoxification of reactive oxygen species. Biochem Mol Biol Educ. 32:183–186.
   PubMed Web of Science ®Google Scholar
• Kumar S, Lombard DB. 2015. Mitochondrial sirtuins and their relationships with metabolic disease and cancer. Antioxid Redox Signal. 22:1060–1077.
   PubMed Web of Science ®Google Scholar
• Kumar S, Lombard DB. 2017a. Cycling around lysine modifications. Trends Biochem Sci. 42:501–503.
   PubMed Web of Science ®Google Scholar
• Kumar S, Lombard DB. 2017b. For certain, SIRT4 activities!. Trends Biochem Sci. 42:499–501.
   PubMed Web of Science ®Google Scholar
• Kurmi K, Hitosugi S, Wiese EK, Boakye-Agyeman F, Gonsalves WI, Lou Z, Karnitz LM, Goetz MP, Hitosugi T. 2018. Carnitine palmitoyltransferase 1A has a lysine succinyltransferase activity. Cell Rep. 22:1365–1373.
   PubMed Web of Science ®Google Scholar
• Lai CC, Lin PM, Lin SF, Hsu CH, Lin HC, Hu ML, Hsu CM, Yang MY. 2013. Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol. 34:1847–1854.
   PubMedGoogle Scholar
• Lakshminarasimhan M, Rauh D, Schutkowski M, Steegborn C. 2013. Sirt1 activation by resveratrol is substrate sequence-selective. Aging (Albany NY). 5:151–154.
   PubMedGoogle Scholar
• Li F, He X, Ye D, Lin Y, Yu H, Yao C, Huang L, Zhang J, Wang F, Xu S, et al. 2015. NADP(+)-IDH mutations promote hypersuccinylation that impairs mitochondria respiration and induces apoptosis resistance. Mol Cell. 60:661–675.
   PubMed Web of Science ®Google Scholar
• Li F, Liu L. 2016. SIRT5 deficiency enhances susceptibility to kainate-induced seizures and exacerbates hippocampal neurodegeneration not through mitochondrial antioxidant enzyme SOD2. Front Cell Neurosci. 10:171.
   PubMed Web of Science ®Google Scholar
• Li L, Shi L, Yang S, Yan R, Zhang D, Yang J, He L, Li W, Yi X, Sun L, et al. 2016. SIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stability. Nat Commun. 7:12235.
   PubMed Web of Science ®Google Scholar
• Li Y, Huang W, You L, Xie T, He B. 2015. A FRET-based assay for screening SIRT5 specific modulators. Bioorg Med Chem Lett. 25:1671–1674.
   PubMed Web of Science ®Google Scholar
• Liang F, Wang X, Ow SH, Chen W, Ong WC. 2017. Sirtuin 5 is anti-apoptotic and anti-oxidative in cultured SH-EP neuroblastoma cells. Neurotox Res. 31:63–76.
   PubMed Web of Science ®Google Scholar
• Liberti MV, Locasale JW. 2016. The warburg effect: how does it benefit cancer cells? Trends Biochem Sci. 41:211–218.
   PubMed Web of Science ®Google Scholar
• Lin HW, Thompson JW, Morris KC, Perez-Pinzon MA. 2011. Signal transducers and activators of transcription: STATs-mediated mitochondrial neuroprotection. Antioxid Redox Signal. 14:1853–1861.
   PubMed Web of Science ®Google Scholar
• Lin ZF, Xu HB, Wang JY, Lin Q, Ruan Z, Liu FB, Jin W, Huang HH, Chen X. 2013. SIRT5 desuccinylates and activates SOD1 to eliminate ROS. Biochem Biophys Res Commun. 441:191–195.
   PubMed Web of Science ®Google Scholar
• Liszt G, Ford E, Kurtev M, Guarente L. 2005. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem. 280:21313–21320.
   PubMed Web of Science ®Google Scholar
• Liu B, Che W, Zheng C, Liu W, Wen J, Fu H, Tang K, Zhang J, Xu Y. 2013. SIRT5: a safeguard against oxidative stress-induced apoptosis in cardiomyocytes. Cell Physiol Biochem. 32:1050–1059.
   PubMed Web of Science ®Google Scholar
• Liu J, Huang Y, Zheng W. 2016. A selective cyclic peptidic human SIRT5 inhibitor. Molecules. 21: E1217.
   PubMed Web of Science ®Google Scholar
• Liu L, Peritore C, Ginsberg J, Shih J, Arun S, Donmez G. 2015. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson’s disease. Behav Brain Res. 281:215–221.
   PubMed Web of Science ®Google Scholar
• Liu S, Ji S, Yu ZJ, Wang HL, Cheng X, Li WJ, Jing L, Yu Y, Chen Q, Yang LL, et al. 2017. Structure-based discovery of new selective small-molecule sirtuin 5 inhibitors. Chem Biol Drug Des. 91:257–268.
   PubMed Web of Science ®Google Scholar
• Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, et al. 2007. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol. 27:8807–8814.
   PubMed Web of Science ®Google Scholar
• Lombard DB, Dash BP, Kumar S. 2015. Acetyl-ed question in mitochondrial biology? EMBO J. 34:2597–2600.
   PubMed Web of Science ®Google Scholar
• Lu W, Zuo Y, Feng Y, Zhang M. 2014. SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer. Tumour Biol. 35:10699–10705.
   PubMed Web of Science ®Google Scholar
• Lv XB, Liu L, Cheng C, Yu B, Xiong L, Hu K, Tang J, Zeng L, Sang Y. 2015. SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer. Sci Rep. 5:17940.
   PubMed Web of Science ®Google Scholar
• Madsen AS, Andersen C, Daoud M, Anderson KA, Laursen JS, Chakladar S, Huynh FK, Colaco AR, Backos DS, Fristrup P, et al. 2016. Investigating the sensitivity of NAD+-dependent sirtuin deacylation activities to NADH. J Biol Chem. 291:7128–7141.
   PubMed Web of Science ®Google Scholar
• Mahlknecht U, Ho AD, Letzel S, Voelter-Mahlknecht S. 2006. Assignment of the NAD-dependent deacetylase sirtuin 5 gene (SIRT5) to human chromosome band 6p23 by in situ hybridization. Cytogenet Genome Res. 112:208–212.
   PubMed Web of Science ®Google Scholar
• Mai A, Massa S, Lavu S, Pezzi R, Simeoni S, Ragno R, Mariotti FR, Chiani F, Camilloni G, Sinclair DA. 2005. Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (Sirtuin) inhibitors. J Med Chem. 48:7789–7795.
   PubMed Web of Science ®Google Scholar
• Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, Seluanov A, Gorbunova V. 2011. SIRT6 promotes DNA repair under stress by activating PARP1. Science. 332:1443–1446.
   PubMed Web of Science ®Google Scholar
• Marcon E, Jain H, Bhattacharya A, Guo H, Phanse S, Pu S, Byram G, Collins BC, Dowdell E, Fenner M, et al. 2015. Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation. Nat Methods. 12:725–731.
   PubMed Web of Science ®Google Scholar
• Mathias RA, Greco TM, Oberstein A, Budayeva HG, Chakrabarti R, Rowland EA, Kang Y, Shenk T, Cristea IM. 2014. Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity. Cell. 159:1615–1625.
   PubMed Web of Science ®Google Scholar
• Matsushita N, Yonashiro R, Ogata Y, Sugiura A, Nagashima S, Fukuda T, Inatome R, Yanagi S. 2011. Distinct regulation of mitochondrial localization and stability of two human Sirt5 isoforms. Genes Cells. 16:190–202.
   PubMed Web of Science ®Google Scholar
• Maurer B, Rumpf T, Scharfe M, Stolfa DA, Schmitt ML, He W, Verdin E, Sippl W, Jung M. 2012. Inhibitors of the NAD(+)-dependent protein desuccinylase and demalonylase Sirt5. ACS Med Chem Lett. 3:1050–1053.
   PubMed Web of Science ®Google Scholar
• Meijer AJ, Lamers WH, Chamuleau RA. 1990. Nitrogen metabolism and ornithine cycle function. Physiol Rev. 70:701–748.
   PubMed Web of Science ®Google Scholar
• Meyer JN, Leuthner TC, Luz AL. 2017. Mitochondrial fusion, fission, and mitochondrial toxicity. Toxicology. 391:42–53.
   PubMed Web of Science ®Google Scholar
• Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, et al. 2008. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 452:492–496.
   PubMed Web of Science ®Google Scholar
• Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I. 2005. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell. 16:4623–4635.
   PubMed Web of Science ®Google Scholar
• Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al. 2007. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 450:712–716.
   PubMed Web of Science ®Google Scholar
• Morris-Blanco KC, Cohan CH, Neumann JT, Sick TJ, Perez-Pinzon MA. 2014. Protein kinase C epsilon regulates mitochondrial pools of Nampt and NAD following resveratrol and ischemic preconditioning in the rat cortex. J Cereb Blood Flow Metab. 34:1024–1032.
   PubMed Web of Science ®Google Scholar
• Morris-Blanco KC, Dave KR, Saul I, Koronowski KB, Stradecki HM, Perez-Pinzon MA. 2016. Protein kinase C epsilon promotes cerebral ischemic tolerance via modulation of mitochondrial Sirt5. Sci Rep. 6:29790.
   PubMed Web of Science ®Google Scholar
• Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, Liu P, Mostoslavsky G, Franco S, Murphy MM, et al. 2006. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 124:315–329.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Lomb DJ, Haigis MC, Guarente L. 2009. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell. 137:560–570.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Ogura M, Ogura K, Tanaka D, Inagaki N. 2012. SIRT5 deacetylates and activates urate oxidase in liver mitochondria of mice. FEBS Lett. 586:4076–4081.
   PubMed Web of Science ®Google Scholar
• Nishida Y, Rardin MJ, Carrico C, He W, Sahu AK, Gut P, Najjar R, Fitch M, Hellerstein M, Gibson BW, et al. 2015. SIRT5 regulates both cytosolic and mitochondrial protein malonylation with glycolysis as a major target. Mol Cell. 59:321–332.
   PubMed Web of Science ®Google Scholar
• North BJ, Verdin E. 2004. Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol. 5:224.
   PubMed Web of Science ®Google Scholar
• Ogura M, Nakamura Y, Tanaka D, Zhuang X, Fujita Y, Obara A, Hamasaki A, Hosokawa M, Inagaki N. 2010. Overexpression of SIRT5 confirms its involvement in deacetylation and activation of carbamoyl phosphate synthetase 1. Biochem Biophys Res Commun. 393:73–78.
   PubMed Web of Science ®Google Scholar
• Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP. 2002. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci USA. 99:13653–13658.
   PubMed Web of Science ®Google Scholar
• Pacella-Ince L, Zander-Fox DL, Lane M. 2014. Mitochondrial SIRT5 is present in follicular cells and is altered by reduced ovarian reserve and advanced maternal age. Reprod Fertil Dev. 26:1072–1083.
   PubMed Web of Science ®Google Scholar
• Paine PL, Moore LC, Horowitz SB. 1975. Nuclear envelope permeability. Nature. 254:109–114.
   PubMed Web of Science ®Google Scholar
• Pannek M, Simic Z, Fuszard M, Meleshin M, Rotili D, Mai A, Schutkowski M, Steegborn C. 2017. Crystal structures of the mitochondrial deacylase Sirtuin 4 reveal isoform-specific acyl recognition and regulation features. Nat Commun. 8:1513.
   PubMed Web of Science ®Google Scholar
• Park J, Chen Y, Tishkoff DX, Peng C, Tan M, Dai L, Xie Z, Zhang Y, Zwaans BM, Skinner ME, et al. 2013. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell. 50:919–930.
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Thompson CB. 2016. The emerging hallmarks of cancer metabolism. Cell Metab. 23:27–47.
   PubMed Web of Science ®Google Scholar
• Peng C, Lu Z, Xie Z, Cheng Z, Chen Y, Tan M, Luo H, Zhang Y, He W, Yang K, et al. 2011. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol Cell Proteomics. 10:M111 012658.
   PubMed Web of Science ®Google Scholar
• Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G. 2015. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab. 21:805–821.
   PubMed Web of Science ®Google Scholar
• Pitkanen A, Lukasiuk K. 2011. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol. 10:173–186.
   PubMed Web of Science ®Google Scholar
• Polletta L, Vernucci E, Carnevale I, Arcangeli T, Rotili D, Palmerio S, Steegborn C, Nowak T, Schutkowski M, Pellegrini L, et al. 2015. SIRT5 regulation of ammonia-induced autophagy and mitophagy. Autophagy. 11:253–270.
   PubMed Web of Science ®Google Scholar
• Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M. 2001. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem. 76:1265–1274.
   PubMed Web of Science ®Google Scholar
• Rajabi N, Auth M, Troelsen KR, Pannek M, Bhatt DP, Fontenas M, Hirschey MD, Steegborn C, Madsen AS, Olsen CA. 2017. Mechanism-based inhibitors of the human Sirtuin 5 deacylase: structure-activity relationship, biostructural, and kinetic insight. Angew Chem Int Ed Engl. 56:14836–14841.
   PubMed Web of Science ®Google Scholar
• Rardin MJ, He W, Nishida Y, Newman JC, Carrico C, Danielson SR, Guo A, Gut P, Sahu AK, Li B, et al. 2013. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab. 18:920–933.
   PubMed Web of Science ®Google Scholar
• Rauh D, Fischer F, Gertz M, Lakshminarasimhan M, Bergbrede T, Aladini F, Kambach C, Becker CF, Zerweck J, Schutkowski M, et al. 2013. An acetylome peptide microarray reveals specificities and deacetylation substrates for all human sirtuin isoforms. Nat Commun. 4:2327.
   PubMed Web of Science ®Google Scholar
• Raval AP, Dave KR, DeFazio RA, Perez-Pinzon MA. 2007. epsilonPKC phosphorylates the mitochondrial K(+) (ATP) channel during induction of ischemic preconditioning in the rat hippocampus. Brain Res. 1184:345–353.
   PubMed Web of Science ®Google Scholar
• Roessler C, Nowak T, Pannek M, Gertz M, Nguyen GT, Scharfe M, Born I, Sippl W, Steegborn C, Schutkowski M. 2014. Chemical probing of the human sirtuin 5 active site reveals its substrate acyl specificity and peptide-based inhibitors. Angew Chem Int Ed Engl. 53:10728–10732.
   PubMed Web of Science ®Google Scholar
• Roessler C, Tuting C, Meleshin M, Steegborn C, Schutkowski M. 2015. A novel continuous assay for the deacylase Sirtuin 5 and other deacetylases. J Med Chem. 58:7217–7223.
   PubMed Web of Science ®Google Scholar
• Ryu D, Jo YS, Lo Sasso G, Stein S, Zhang H, Perino A, Lee JU, Zeviani M, Romand R, Hottiger MO, et al. 2014. A SIRT7-dependent acetylation switch of GABPβ1 controls mitochondrial function. Cell Metab. 20:856–869.
   PubMed Web of Science ®Google Scholar
• Sabari BR, Zhang D, Allis CD, Zhao Y. 2017. Metabolic regulation of gene expression through histone acylations. Nat Rev Mol Cell Biol. 18:90–101.
   PubMed Web of Science ®Google Scholar
• Sadhukhan S, Liu X, Ryu D, Nelson OD, Stupinski JA, Li Z, Chen W, Zhang S, Weiss RS, Locasale JW, et al. 2016. Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function. Proc Natl Acad Sci USA. 113:4320–4325.
   PubMed Web of Science ®Google Scholar
• Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, Steegborn C. 2008. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol. 382:790–801.
   PubMed Web of Science ®Google Scholar
• Schuetz A, Min J, Antoshenko T, Wang CL, Allali-Hassani A, Dong A, Loppnau P, Vedadi M, Bochkarev A, Sternglanz R, et al. 2007. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin. Structure. 15:377–389.
   PubMed Web of Science ®Google Scholar
• Schwer B, North BJ, Frye RA, Ott M, Verdin E. 2002. The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol. 158:647–657.
   PubMed Web of Science ®Google Scholar
• Smith BC, Denu JM. 2007. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide. Biochemistry. 46:14478–14486.
   PubMed Web of Science ®Google Scholar
• Sohal RS, Weindruch R. 1996. Oxidative stress, caloric restriction, and aging. Science. 273:59–63.
   PubMed Web of Science ®Google Scholar
• Stacpoole PW. 2017. Therapeutic targeting of the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis in cancer. J Natl Cancer Inst. 109:djx071. https://doi.org/10.1093/jnci/djx071.
   Google Scholar
• Suenkel B, Fischer F, Steegborn C. 2013. Inhibition of the human deacylase Sirtuin 5 by the indole GW5074. Bioorg Med Chem Lett. 23:143–146.
   PubMed Web of Science ®Google Scholar
• Sun JY, Xu L, Tseng H, Ciccarelli B, Fulciniti M, Hunter ZR, Maghsoudi K, Hatjiharissi E, Zhou Y, Yang G, et al. 2011. Histone deacetylase inhibitors demonstrate significant preclinical activity as single agents, and in combination with bortezomib in Waldenström’s macroglobulinemia. Clin Lymphoma Myeloma Leuk. 11:152–156.
   PubMed Web of Science ®Google Scholar
• Sundaresan NR, Bindu S, Pillai VB, Samant S, Pan Y, Huang JY, Gupta M, Nagalingam RS, Wolfgeher D, Verdin E, et al. 2015. SIRT3 Blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3β. Mol Cell Biol. 36:678–692.
   PubMed Web of Science ®Google Scholar
• Takeshita A, Naito K, Shinjo K, Sahara N, Matsui H, Ohnishi K, Beppu H, Ohtsubo K, Horii T, Maekawa M, et al. 2004. Deletion 6p23 and add(11)(p15) leading to NUP98 translocation in a case of therapy-related atypical chronic myelocytic leukemia transforming to acute myelocytic leukemia. Cancer Genet Cytogenet. 152:56–60.
   PubMedGoogle Scholar
• Tan M, Peng C, Anderson KA, Chhoy P, Xie Z, Dai L, Park J, Chen Y, Huang H, Zhang Y, et al. 2014. Lysine glutarylation is a protein posttranslational modification regulated by SIRT5. Cell Metab.19:605–617.
   PubMed Web of Science ®Google Scholar
• Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y. 2007. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem. 282:6823–6832.
   PubMed Web of Science ®Google Scholar
• Tasselli L, Zheng W, Chua KF. 2017. SIRT6: novel mechanisms and links to aging and disease. Trends Endocrinol Metab. 28:168–185.
   PubMed Web of Science ®Google Scholar
• Teng YB, Jing H, Aramsangtienchai P, He B, Khan S, Hu J, Lin H, Hao Q. 2015. Efficient demyristoylase activity of SIRT2 revealed by kinetic and structural studies. Sci Rep. 5:8529.
   PubMed Web of Science ®Google Scholar
• TenNapel MJ, Lynch CF, Burns TL, Wallace R, Smith BJ, Button A, Domann FE. 2014. SIRT6 minor allele genotype is associated with >5-year decrease in lifespan in an aged cohort. PLoS One. 9:e115616.
   PubMed Web of Science ®Google Scholar
• Tong Z, Wang M, Wang Y, Kim DD, Grenier JK, Cao J, Sadhukhan S, Hao Q, Lin H. 2017. SIRT7 is an RNA-activated protein lysine deacylase. ACS Chem Biol. 12:300–310.
   PubMed Web of Science ®Google Scholar
• Trapp J, Jochum A, Meier R, Saunders L, Marshall B, Kunick C, Verdin E, Goekjian P, Sippl W, Jung M. 2006. Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition. J Med Chem. 49:7307–7316.
   PubMed Web of Science ®Google Scholar
• Trapp J, Meier R, Hongwiset D, Kassack MU, Sippl W, Jung M. 2007. Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins). ChemMedChem. 2:1419–1431.
   PubMed Web of Science ®Google Scholar
• Van Meter M, Kashyap M, Rezazadeh S, Geneva AJ, Morello TD, Seluanov A, Gorbunova V. 2014. SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age. Nat Commun. 5:5011.
   PubMed Web of Science ®Google Scholar
• Vaquero A, Scher MB, Lee DH, Sutton A, Cheng HL, Alt FW, Serrano L, Sternglanz R, Reinberg D. 2006. SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 20:1256–1261.
   PubMed Web of Science ®Google Scholar
• Voelter-Mahlknecht S, Mahlknecht U. 2013. Cloning, chromosomal characterization and FISH mapping of the NAD(+)-dependent histone deacetylase gene sirtuin 5 in the mouse. Int J Oncol. 43:237–245.
   PubMed Web of Science ®Google Scholar
• Wagner GR, Bhatt DP, O’Connell TM, Thompson JW, Dubois LG, Backos DS, Yang H, Mitchell GA, Ilkayeva OR, Stevens RD, et al. 2017. A class of reactive acyl-CoA species reveals the non-enzymatic origins of protein acylation. Cell Metab. 25:823–837.e8.
   PubMed Web of Science ®Google Scholar
• Wagner GR, Hirschey MD. 2014. Nonenzymatic protein acylation as a carbon stress regulated by sirtuin deacylases. Mol Cell. 54:5–16.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang K, Xu W, Zhao S, Ye D, Wang Y, Xu Y, Zhou L, Chu Y, Zhang C, et al. 2017. SIRT5 desuccinylates and activates pyruvate kinase M2 to block macrophage IL-1beta production and to prevent DSS-induced colitis in mice. Cell Rep. 19:2331–2344.
   PubMed Web of Science ®Google Scholar
• Wang P, Guan YF, Du H, Zhai QW, Su DF, Miao CY. 2012. Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia. Autophagy. 8:77–87.
   PubMed Web of Science ®Google Scholar
• Wang Q, Yu S, Simonyi A, Sun GY, Sun AY. 2005. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol Neurobiol. 31:3–16.
   PubMed Web of Science ®Google Scholar
• Wang WW, Zeng Y, Wu B, Deiters A, Liu WR. 2016. A chemical biology approach to reveal Sirt6-targeted histone H3 sites in nucleosomes. ACS Chem Biol. 11:1973–1981.
   PubMed Web of Science ®Google Scholar
• Wang Y, Guo YR, Liu K, Yin Z, Liu R, Xia Y, Tan L, Yang P, Lee JH, Li XJ, et al. 2017. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase . Nature. 552:273–277.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu Y, Xing S, Ma P, Lin D. 2015. SIRT5 prevents cigarette smoke extract-induced apoptosis in lung epithelial cells via deacetylation of FOXO3. Cell Stress Chaperones. 20:805–810.
   PubMed Web of Science ®Google Scholar
• Wang YQ, Wang HL, Xu J, Tan J, Fu LN, Wang JL, Zou TH, Sun DF, Gao QY, Chen YX, et al. 2018. Sirtuin5 contributes to colorectal carcinogenesis by enhancing glutaminolysis in a deglutarylation-dependent manner. Nat Commun. 9:545.
   PubMed Web of Science ®Google Scholar
• Weinert BT, Moustafa T, Iesmantavicius V, Zechner R, Choudhary C. 2015. Analysis of acetylation stoichiometry suggests that SIRT3 repairs nonenzymatic acetylation lesions. EMBO J. 34:2620–2632.
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. 2009. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 324:1076–1080.
   PubMed Web of Science ®Google Scholar
• White CJ, Yudin AK. 2011. Contemporary strategies for peptide macrocyclization. Nat Chem. 3:509–524.
   PubMed Web of Science ®Google Scholar
• Williams AC, Ramsden DB. 2005. Autotoxicity, methylation and a road to the prevention of Parkinson’s disease. J Clin Neurosci. 12:6–11.
   PubMed Web of Science ®Google Scholar
• Xiangyun Y, Xiaomin N, Linping G, Yunhua X, Ziming L, Yongfeng Y, Zhiwei C, Shun L. 2017. Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth. Oncotarget. 8:6984–6993.
   PubMedGoogle Scholar
• Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, Ito S, Yang C, Wang P, Xiao MT, et al. 2011. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell. 19:17–30.
   PubMed Web of Science ®Google Scholar
• Xu YS, Liang JJ, Wang Y, Zhao XJ, Xu L, Xu YY, Zou QC, Zhang JM, Tu CE, Cui YG, et al. 2016. STAT3 undergoes acetylation-dependent mitochondrial translocation to regulate pyruvate metabolism. Sci Rep. 6:39517.
   PubMed Web of Science ®Google Scholar
• Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D, Aldape K, Hunter T, Alfred Yung WK, Lu Z. 2012. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell. 150:685–696.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang Z, Li X, Liu B, Liu M, Liu L, Chen S, Ren M, Wang Y, Yu M, et al. 2017. SHMT2 desuccinylation by SIRT5 drives cancer cell proliferation. Cancer Res. 78:372–386.
   PubMed Web of Science ®Google Scholar
• Yu J, Sadhukhan S, Noriega LG, Moullan N, He B, Weiss RS, Lin H, Schoonjans K, Auwerx J. 2013. Metabolic characterization of a Sirt5 deficient mouse model. Sci Rep. 3:2806.
   PubMed Web of Science ®Google Scholar
• Zang W, Hao Y, Wang Z, Zheng W. 2015. Novel thiourea-based sirtuin inhibitory warheads. Bioorg Med Chem Lett. 25:3319–3324.
   PubMed Web of Science ®Google Scholar
• Zeng J, Li D. 2004. Expression and purification of his-tagged rat peroxisomal acyl-CoA oxidase I wild-type and E421 mutant proteins. Protein Expr Purif. 38:153–160.
   PubMed Web of Science ®Google Scholar
• Zhan L, Huang C, Meng XM, Song Y, Wu XQ, Miu CG, Zhan XS, Li J. 2014. Promising roles of mammalian E2Fs in hepatocellular carcinoma. Cell Signal. 26:1075–1081.
   PubMed Web of Science ®Google Scholar
• Zhang W, Xie Y, Wang T, Bi J, Li H, Zhang LQ, Ye SQ, Ding S. 2010. Neuronal protective role of PBEF in a mouse model of cerebral ischemia. J Cereb Blood Flow Metab. 30:1962–1971.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bharathi SS, Rardin MJ, Lu J, Maringer KV, Sims-Lucas S, Prochownik EV, Gibson BW, Goetzman ES. 2017. Lysine desuccinylase SIRT5 binds to cardiolipin and regulates the electron transport chain. J Biol Chem. 292:10239–10249.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bharathi SS, Rardin MJ, Uppala R, Verdin E, Gibson BW, Goetzman ES. 2015. SIRT3 and SIRT5 regulate the enzyme activity and cardiolipin binding of very long-chain acyl-CoA dehydrogenase. PLoS One. 10:e0122297.
   PubMed Web of Science ®Google Scholar
• Zhao T, Mu X, You Q. 2017. Succinate: an initiator in tumorigenesis and progression. Oncotarget. 8:53819–53828.
   PubMedGoogle Scholar
• Zhou L, Wang F, Sun R, Chen X, Zhang M, Xu Q, Wang Y, Wang S, Xiong Y, Guan KL, et al. 2016. SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to enhance cellular antioxidant defense. EMBO Rep. 17:811–822.
   PubMed Web of Science ®Google Scholar
• Zhu WZ, Wu XF, Zhang Y, Zhou ZN. 2012. Proteomic analysis of mitochondrial proteins in cardiomyocytes from rats subjected to intermittent hypoxia. Eur J Appl Physiol. 112:1037–1046.
   PubMed Web of Science ®Google Scholar
• Zorov DB, Juhaszova M, Sollott SJ. 2014. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 94:909–950.
   PubMed Web of Science ®Google Scholar